Category: Sector

Executive Moves

Lovett Care has appointed Melanie Phillips as head of marketing, tasked with boosting occupancy, developing the company’s brand, and leading digital plans.

Social care
Executive Moves

Optibrium: James Halle

  • 16 July 2024

Optibrium, a drug discovery software provider to the pharmaceutical and biotech industries, has appointed James Halle as chief commercial officer.

Pharma
Executive Moves

Cellular Origins, a TTP company focused on enabling manufacture of cell and gene therapies, has appointed Geoffrey Hodge as a non-executive director.

Pharma
Executive Moves

Commercial finance broker Chandler & Co has recruited Dan Hewitt as a senior broker. The firm finances businesses in the social care sector. 

Social care
Executive Moves

CN Bio: Lydia Seymour

  • 27 June 2024

Cambridge-based CN Bio has appointed Lydia Seymour as vice-president of people and culture.

Pharma
News

London based social care workforce management firm, Care Hires, has raised £1.7 million to advance its AI-driven agency staffing services.

Fundraising
Executive Moves

Home care group Bluebird Care has appointed Melony Fairchild as operations director, overseeing five offices across Southeast England and London.

Social care
Executive Moves

Livi: Tom Davis

  • 25 June 2024

Digital healthcare provider Livi has appointed Tom Davis as UK medical director.

Technology
News

Cambridge Cognition has completed a raise of £2.6 million (£2.1 million net) from a placing, open offer and subscription, with shares commencing trading today.

Technology
News

London-based medical technology firm, Amber Therapeutics, has raised $100 million from investors to support development of fully implantable adaptive neuromodulation therapy for women with mixed urinary incontinence (MUI).

Fundraising
News

Cloud21 acquired BDS Solutions, which provides IT consultancy, support services and products to NHS trusts and UK healthcare organisations.

M&A
Executive Moves

Enhanc3D Genomics, which develops disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, has appointed Hazel Jones as chief executive.

Pharma

Partners

Join our mailing list

Stay up to date with all our events, awards and publications.

Information you provide us with will be kept private at all times, and will be used for communication and research purpose only.